We are live on ! Find out more
Clarius Group

Clarius Group Portfolio holdings

AUM $1.75B Turnover 9.73%
1-Year Est. Return 19.04%
 

Clarius Group is a multi-family office that serves ultra-high-net-worth individuals and families. It provides investment advice, family office services and personal accounting. Keith Vernon and Matthew Talbot are among its founding partners. Clearstead Advisors, an investment adviser, bought the firm in a deal that closed in January 2026.

This Fund
S&P 500
This Quarter Est. Return
+6.98%
1 Year Est. Return
+19.04%
3 Year Est. Return
+92.07%
5 Year Est. Return
+98.79%
10 Year Est. Return
+415.93%
AUM
$238M
AUM Growth
-$5.15M
Cap. Flow
-$16.6M
Cap. Flow %
-6.98%
Top 10 Hldgs %
73.68%
Holding
100
New
5
Increased
11
Reduced
37
Closed
30
Avg Time Held
1.4 years
Top 10 Avg Time Held
1.3 years
Top 20 Avg Time Held
1.3 years

Top Sells

Rank Stock Value
1
PI icon
Impinj
PI
+$2.05M
2
SAGE icon
Sage Therapeutics
SAGE
+$1.57M
3
AAPL icon
Apple
AAPL
+$1.43M
4
AMZN icon
Amazon
AMZN
+$1.26M
5
MSFT icon
Microsoft
MSFT
+$856K

Sector Composition

Rank Sector Weight
1 Industrials 38.26%
2 Miscellaneous 27.03%
3 Consumer Discretionary 14.01%
4 Healthcare 9.82%
5 Technology 4.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
PCAR icon
1
PACCAR
PCAR
$56.2B
$90.1M 37.92%
1,867,551
-765
-0% -$34.5K
2015 Q4
7 quarters
AMZN icon
2
Amazon
AMZN
$2.88T
$28.6M 12.06%
595,880
-25,620
-4% -$1.26M
2015 Q4
7 quarters
VUG icon
3
Vanguard Morningstar Growth ETF
VUG
$219B
$16.9M 7.12%
764,514
+3,144
+0.4% +$68.4K
2015 Q4
7 quarters
SAGE icon
4
DELISTED
Sage Therapeutics
SAGE
$8.04M 3.39%
129,068
-20,000
-13% -$1.57M
2016 Q1
6 quarters
AGIO icon
5
Agios Pharmaceuticals
AGIO
$1.89B
$7.29M 3.07%
109,230
– –
2016 Q1
6 quarters
IWB icon
6
iShares Russell 1000 ETF
IWB
$47.9B
$5.51M 2.32%
39,408
– –
2015 Q4
7 quarters
VTV icon
7
Vanguard Morningstar Value ETF
VTV
$197B
$5.36M 2.26%
53,668
+12,806
+31% +$1.25M
2015 Q4
7 quarters
JUNO
8
DELISTED
Juno Therapeutics, Inc.
JUNO
$5.29M 2.23%
117,896
-128
-0.1% -$4.36K
2015 Q4
7 quarters
IEMG icon
9
iShares Core MSCI Emerging Markets ETF
IEMG
$146B
$4.01M 1.69%
74,216
-1,300
-2% -$69K
2016 Q1
6 quarters
AAPL icon
10
Apple
AAPL
$5.18T
$3.87M 1.63%
100,472
-36,768
-27% -$1.43M
2015 Q4
7 quarters
IWD icon
11
iShares Russell 1000 Value ETF
IWD
$84.9B
$3.64M 1.53%
30,676
– –
2015 Q4
7 quarters
SBUX icon
12
Starbucks
SBUX
$121B
$3.35M 1.41%
62,423
-4,063
-6% -$225K
2015 Q4
7 quarters
VEU icon
13
Vanguard FTSE All-World ex-US ETF
VEU
$66.6B
$2.76M 1.16%
52,329
+298
+0.6% +$15.4K
2015 Q4
7 quarters
META icon
14
Meta Platforms (Facebook)
META
$1.64T
$2.58M 1.09%
15,096
-3,254
-18% -$543K
2015 Q4
7 quarters
ACWI icon
15
iShares MSCI ACWI ETF
ACWI
$32.6B
$2.56M 1.08%
37,162
-2,920
-7% -$196K
2015 Q4
7 quarters
GOOGL icon
16
Alphabet (Google) Class A
GOOGL
$3.64T
$2.52M 1.06%
51,700
-6,420
-11% -$304K
2015 Q4
7 quarters
VBR icon
17
Vanguard Morningstar Small-Cap Value ETF
VBR
$37.5B
$2.46M 1.04%
19,288
+1,067
+6% +$132K
2015 Q4
7 quarters
GOOG icon
18
Alphabet (Google) Class C
GOOG
$3.6T
$2.26M 0.95%
47,020
-7,280
-13% -$339K
2015 Q4
7 quarters
PI icon
19
Impinj
PI
$5.2B
$2.18M 0.92%
52,496
-48,666
-48% -$2.05M
2016 Q3
4 quarters
EDIT icon
20
Editas Medicine
EDIT
$335M
$2.09M 0.88%
87,231
– –
2016 Q3
4 quarters
RAMP icon
21
DELISTED
LiveRamp
RAMP
$2.04M 0.86%
82,814
+2,308
+3% +$56.7K
2015 Q4
7 quarters
BRK.A icon
22
Berkshire Hathaway Class A
BRK.A
$1.26T
$1.92M 0.81%
+7
New +$1.86M
2017 Q3
0 quarters
MSFT icon
23
Microsoft
MSFT
$3.89T
$1.87M 0.79%
25,078
-11,718
-32% -$856K
2015 Q4
7 quarters
SJNK icon
24
State Street SPDR Bloomberg Short Term High Yield Bond ETF
SJNK
$4.32B
$1.86M 0.78%
66,500
– –
2016 Q4
3 quarters
IXUS icon
25
iShares Core MSCI Total International Stock ETF
IXUS
$57.7B
$1.79M 0.76%
29,417
– –
2016 Q1
6 quarters

Similar funds

Clarius Group's Q3 2017 Portfolio in Review

As of Q3 2017, Clarius Group held 100 positions worth $238M, down 2.1% from $243M the previous quarter. Its ten largest holdings account for 74% of the portfolio.

Clarius Group withdrew a net $16.6M in Q3 2017, closing 30 positions and reducing 37 holdings. Its most notable exit was bluebird bio, an estimated $765K position sold in full.

By sector, the portfolio is most concentrated in Industrials at 38% of assets, up from 35% a quarter earlier, followed by Miscellaneous and Consumer Discretionary.

Against the trend, Clarius Group opened a new position in Berkshire Hathaway Class A worth $1.92M.

  • Clarius Group's largest Q3 2017 buy was Berkshire Hathaway Class A: 7 shares worth $1.92M.
  • Clarius Group added most to Vanguard Morningstar Value ETF in Q3 2017, an estimated $1.25M increase.
  • Clarius Group's biggest Q3 2017 reduction was Impinj, cutting an estimated $2.05M.
  • Clarius Group fully exited bluebird bio in Q3 2017, selling an estimated $765K.
  • Clarius Group's ten largest holdings make up 74% of its $238M portfolio in Q3 2017.
  • Clarius Group opened 5 new positions and closed 30 in Q3 2017.
  • Clarius Group's portfolio value fell 2.1% quarter-over-quarter to $238M.

Based on Clarius Group's 13F filing for Q3 2017, filed 7 Nov 2017.